Complete response to paclitaxel, ifosfamide, and cisplatin therapy in a case of ovarian ependymoma

Makiko Hino, Yusuke Kobayashi, Michiko Wada, Yoshihisa Hattori, Takashi Kurahasi, Hiroyuki Nakagawa

研究成果: Article査読

4 被引用数 (Scopus)

抄録

There are many reports on paclitaxel, ifosfamide, and cisplatin (TIP) therapy, following standard bleomycin, etoposide, and cisplatin (BEP) therapy, for salvage treatment of testicular malignant germ cell tumors, but there are no reports on its use for ovarian malignant tumors. We report here that a patient with primary ependymoma of the ovary, who was resistant to BEP therapy, achieved a complete response to a combined therapy, including TIP therapy as the second-line chemotherapy and surgery. This important case, combined with published studies, suggests that TIP therapy is effective for both testicular and ovarian malignant tumors and indicates that TIP therapy can be used as an effective second-line therapy for malignant tumors resistant to BEP therapy.

本文言語English
ページ(範囲)1613-1617
ページ数5
ジャーナルJournal of Obstetrics and Gynaecology Research
42
11
DOI
出版ステータスPublished - 2016 11 1

ASJC Scopus subject areas

  • 産婦人科学

フィンガープリント

「Complete response to paclitaxel, ifosfamide, and cisplatin therapy in a case of ovarian ependymoma」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル